logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Advances In Targeted Cancer Therapy Progress In Drug Research 1st Edition Richard M Schultz Editor

  • SKU: BELL-2006086
Advances In Targeted Cancer Therapy Progress In Drug Research 1st Edition Richard M Schultz Editor
$ 31.00 $ 45.00 (-31%)

4.3

48 reviews

Advances In Targeted Cancer Therapy Progress In Drug Research 1st Edition Richard M Schultz Editor instant download after payment.

Publisher: Birkhäuser
File Extension: PDF
File size: 1.38 MB
Pages: 310
Author: Richard M. Schultz (Editor)
ISBN: 9783764371746, 9783764374143, 3764371749, 3764374144
Language: English
Year: 2005
Edition: 1

Product desciption

Advances In Targeted Cancer Therapy Progress In Drug Research 1st Edition Richard M Schultz Editor by Richard M. Schultz (editor) 9783764371746, 9783764374143, 3764371749, 3764374144 instant download after payment.

This volume is the first book to cover the general topic of targeted cancer therapy. It presents a range of targets such as tumor angiogenesis, cell cycle control and cell signalling, COX-2, apoptosis/cell survival, invasion and metastasis and approaches like kinase inhibitors, antisense, and antibody-based therapeutics. The emphasis is on preclinical development, including target validation, development of biomarkers, strategies for combination approaches, and development of resistance. The particular challenges involved in translating these data to clinical application are discussed. This volume should be of broad general interest to researchers and clinicians involved in cancer therapy as well as other scientists interested in current strategies for cancer treatment.

Related Products